 | | PRD_000390 | | Name: | N-(tert-butoxycarbonyl)-L-alanyl-N-{(1R)-5-ammonio-1-[hydroxy(methoxy)boranyl]pentyl}-L-valinamide | | Formula: | C19 H40 B N4 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000411 | | Name: | N-acetyl-L-alanyl-6-ammonio-N-[(1R)-4-carbamimidamido-1-(dihydroxyboranyl)butyl]-L-norleucinamide | | Formula: | C16 H35 B N7 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000420 | | Name: | AC-ARG-GLU-LYS-BOROARG PEPTIDYL BORONIC ACID INHIBITOR | | Formula: | C24 H50 B N11 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000556 | | Name: | AERUGINOSIN 98-B | | Formula: | C29 H46 N6 O9 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000755 | | Name: | BOC ALA ALA PRO PVA | | Formula: | C20 H37 N4 O8 P | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_002353 | | Name: | Blood group B type 1 antigen, beta anomer | | Formula: | C26 H45 N O20 | | Definition date: | 2022-03-02 | | Last modified: | 2023-06-11 |
|
 | | PRD_002441 | | Name: | Myxovalargin B | | Formula: | C80 H136 N21 O17 | | Definition date: | 2023-01-25 | | Last modified: | 2023-05-11 |
|
 | | PRD_900134 | | Name: | Blood group B H type 2 antigen, beta anomer | | Formula: | C26 H45 N O20 | | Description: | oligosaccharide with branches | | Definition date: | 2021-02-17 | | Last modified: | 2021-02-17 |
|
 | | PRD_002373 | | Name: | ACE-VAL-ARG-MET-B2A | | Formula: | C20 H41 B N7 O6 S | | Definition date: | 2020-09-16 | | Last modified: | 2020-09-16 |
|
 | | PRD_900029 | | Name: | beta-D-fructofuranosyl-(2->1)-beta-D-fructofuranosyl alpha-D-glucopyranoside | | Formula: | C18 H32 O16 | | Description: | oligosaccharide with reducing-end-to-reducing-end glycosidic bond | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900040 | | Name: | DEOXY-2-FLUORO-B-D-CELLOTRIOSIDE | | Formula: | C18 H31 F O15 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900050 | | Name: | 2-DEOXY-2-FLUORO-B-D-CELLOBIOSIDE | | Formula: | C12 H21 F O10 | | Description: | oligosaccharide | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900085 | | Name: | 6-deoxy-alpha-L-galactopyranosyl-(1->4)-[6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)]-2-(ace
tylamino)-2-deoxy-alpha-D-glucopyranose | | Formula: | C26 H45 N O19 | | Description: | oligosaccharide with branches | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900123 | | Name: | Lewis B antigen, beta anomer | | Formula: | C26 H45 N O19 | | Description: | oligosaccharide with branches | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_900126 | | Name: | Blood group A Lewis B antigen, beta anomer | | Formula: | C34 H58 N2 O24 | | Description: | oligosaccharide with branches | | Definition date: | 2020-07-29 | | Last modified: | 2020-07-29 |
|
 | | PRD_002261 | | Formula: | C92 H138 N27 O24 S | | Description: | single helix from the B-domain of protein A bound to IgG1 Fc | | Definition date: | 2017-05-24 | | Last modified: | 2017-05-24 |
|
 | | PRD_001131 | | Name: | GRAMICIDIN A | | Formula: | C90 H133 N19 O17 | | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS.
THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2013-07-02 | | Last modified: | 2017-05-04 |
|
 | | PRD_002101 | | Name: | N-[(6R,9S,10R,13S,15aR,22S,24aR)-22-[4-(dimethylamino)benzyl]-6-ethyl-10,23-dimethyl-18-(morpholin-4-ylmethyl)-5,8,12,15,21,24-hexaoxo-13-phenyl-1,2,3,5,6,7,8,9,10,13,14,15,15a,16,19,21,22,23,24,24a-icosahydro-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxypyridine-2-carboxamide | | Formula: | C50 H63 N9 O10 | | Definition date: | 2014-07-30 | | Last modified: | 2014-07-30 |
|
 | | PRD_001219 | | Name: | Lantibiotic 107891 | | Formula: | C94 H127 Cl N26 O26 S5 | | Description: | NAI-107 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO DEHYDRATED AA AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE CARBOXY-TERMINAL BETA-METHYLLANTHIONINE UNDERGOES DECARBOXYLATION. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR. | | Definition date: | 2014-03-05 | | Last modified: | 2014-03-05 |
|
 | | PRD_001185 | | Name: | CONANTOKIN BK-B | | Formula: | C46 H64 N10 O25 | | Definition date: | 2014-02-19 | | Last modified: | 2014-02-19 |
|
 | | PRD_001127 | | Name: | GRAMICIDIN A | | Formula: | C103 H140 N20 O17 | | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2013-07-10 | | Last modified: | 2013-07-10 |
|
 | | PRD_001128 | | Name: | GRAMICIDIN C | | Formula: | C101 H139 N19 O18 | | Description: | GRAMICIDIN A IS A HEXADECAMERIC HELICAL PEPTIDE WITH ALTERNATING D,L CHARACTERISTICS. THE N-TERM IS FORMYLATED (RESIDUE 0). THE C-TERM IS CAPPED WITH ETHANOLAMINE (RESIDUE 16). | | Definition date: | 2013-07-01 | | Last modified: | 2013-07-01 |
|
 | | PRD_000909 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-leucinamide | | Formula: | C25 H42 B N3 O6 | | Definition date: | 2013-06-26 | | Last modified: | 2013-06-26 |
|
 | | PRD_000798 | | Name: | (3R,3aR,5R,6aR)-3-hydroxyhexahydro-2H-cyclopenta[b]furan-5-yl [(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]carbamate | | Formula: | C29 H40 N2 O8 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
